[System evaluation on Ginkgo Biloba extract in the treatment of acute cerebral infarction]

Wang et al., 2015 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | Meta Analysis

Citation

Wang Lin, Zhang Tao, Bai Kezhen. [System evaluation on Ginkgo Biloba extract in the treatment of acute cerebral infarction]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015-Oct;40(10):1096-102. doi:10.11817/j.issn.1672-7347.2015.10.007

Abstract

OBJECTIVE: To evaluate the effect and safety of Ginkgo Biloba extract on the treatment of acute cerebral infarction. METHODS: The Database of Wanfang, China National Knowledge Infrastructure (CNKI) and VIPU were screened for literatures regarding Ginkgo Biloba extract in the treatment of acute cerebral infarction, including the clinical randomized controlled trials. Meta-analysis based on the Revman 4.2 system was performed. RESULTS: Compared with the control group, treatment with Ginkgo Biloba extract enhanced efficacy in the treatment of acute cerebral infarction (OR: 1.60-5.53), which displayed an improved neural function defect score [WMD -3.12 (95%CI: -3.96- -2.28)]. CONCLUSION: Ginkgo Biloba extract is beneficial to the improvement of neurological function in patients with acute cerebral infarction and it is safe for patients.

Key Findings

Compared with the control group, treatment with Ginkgo Biloba extract enhanced efficacy in the treatment of acute cerebral infarction (OR: 1.60-5.53), which displayed an improved neural function defect score [WMD -3.12 (95%CI: -3.96- -2.28)].

Outcomes Measured

• Requires manual extraction

Population

MeSH Terms

• Cerebral Infarction
• Ginkgo biloba
• Humans
• Phytotherapy
• Plant Extracts
• Randomized Controlled Trials as Topic

Evidence Classification

• Level: Meta Analysis
• Publication Types: Journal Article, Meta-Analysis
• Vertical: ginkgo

Provenance

• PMID: 26541843
• DOI: 10.11817/j.issn.1672-7347.2015.10.007
• PMCID: Not in PMC
• Verified: 2026-04-09 via PubMed E-utilities API

Source extracted via PubMed E-utilities API on 2026-04-09